Protagenic Therapeutics Inc (PTIX) Live Share Price, Invest From India

Protagenic Therapeutics Inc Stock Performance

as on February 13, 2026 at 7:29 am IST

Day's Low
Day's High
$0.52
Day's Price Range
$0.63
$0.47
-10.64%
Downside
34.04%
Upside
52 Week's Low
52 Week's High
$0.26
52-Week Price Range
$14.28
$0.47
44.66%
Downside
2938.30%
Upside

Protagenic Therapeutics Inc share price movements today

Previous Close: $0.57
Open: $0.52
Volume: 502.0K
Day's Low - High: $0.52 - $0.63
52 Week Low - High: $0.26 - $14.28

Protagenic Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Protagenic Therapeutics Inc Stock Fundamentals & Key Indicators

Check Protagenic Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Protagenic Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Protagenic Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Protagenic Therapeutics Inc	BUY	$-	NA	NA	0.00%
Insmed Incorporated	BUY	$31.2B	249.86%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$42.5B	95.34%	1109.48	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$118.3B	117.32%	32.46	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$82.4B	61.37%	18.8	31.41%

Analyst Recommendation on Protagenic Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Protagenic Therapeutics Inc. Average target price of $4

Protagenic Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Protagenic Therapeutics Inc.

What analysts predicted

88.25%UPSIDE

Target Price

Current Price

$0.47

Analyzed by

7 Analysts

Target

$4.00

Protagenic Therapeutics Inc target price $4, a slight upside of 88.25% compared to current price of $0.47. According to 7 analysts rating.

Protagenic Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	-	0	-	0	0	-	-	-
Gross Profit	0	0	-	0	0	0	0	0	0	-
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-1	-1	-1	-1	-1	0	-1	-1	-5	0
Net Profit Margin	0.00%	0.00%	0.00%	-53875.00%	0.00%	-2549.42%	6180.65%	0.00%	0.00%	0.00%

Protagenic Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	0	0	0	0	0	-	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	0	-2	-2	-2	-1	-2	-4	-3	-5	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Protagenic Therapeutics Inc

Funds	Holdings
Citigroup Inc	0.07%
HARBOR INVESTMENT ADVISORY, LLC	0%
Vanguard Group Inc	0%
Alpine Partners VI, LLC	2.78%
Morgan Stanley - Brokerage Accounts	2.55%

See all

Insights on Protagenic Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 165.0% return, outperforming this stock by 257.9%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 847.0% return, outperforming this stock by 944.6%
NEGATIVE IMPACT
Price Dip
In the last 7 days, PTIX stock has moved down by -56.2%

About Protagenic Therapeutics Inc

Protagenic Therapeutics, Inc. is a neuroactive biopharmaceutical company. The Company has approximately six drug candidates targeting stress-related and CNS disorders, including treatments for obesity and metabolic disorders. The Company's pipeline includes PT-00114 in Phase I/IIa and five preclinical assets including PHYX-001, cannabinoid-based compounds, and modified stilbenoid assets. The PHYX-001 is a potassium channel modulator with a mechanism similar to XEN1101 and BHV-7000. The Company's cannabinoid assets include multiple cannabinoid-based compounds with composition-of-matter IP; potential in CNS, cardiometabolic, and other indications. The Company's cannabinoid assets also include a molecule with potential in the obesity, metabolic dysfunction sector, where the GLP-1 agonists have become medications. Its modified stilbenoid assets include modified stilbenoid compounds with composition-of-matter IP and anticonvulsant activity in preclinical models.

Organisation	Protagenic Therapeutics Inc
E-voting on shares	Click here to vote

FAQs

What is Protagenic Therapeutics Inc share price today?

Protagenic Therapeutics Inc share price today is $0.47 as on February 13, 2026 at 1:59 am IST. Protagenic Therapeutics Inc share today touched a day high of $0.63 and a low of $0.52.

What is the 52 week high and 52 week low for Protagenic Therapeutics Inc share?

Protagenic Therapeutics Inc share touched a 52 week high of $14.28 on May 19, 2025 and a 52 week low of $0.26 on January 5, 2026. Protagenic Therapeutics Inc stock price today i.e. February 13, 2026 at 1:59 am IST is trending at $0.47,which is 96.71% down from its 52 week high and 80.70% up from its 52 week low.

How to invest in Protagenic Therapeutics Inc Stock (PTIX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Protagenic Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Protagenic Therapeutics Inc Shares that will get you 3.1915 shares as per Protagenic Therapeutics Inc share price of $0.47 per share as on February 13, 2026 at 1:59 am IST.

What is the minimum amount required to buy Protagenic Therapeutics Inc Stock (PTIX) from India?

Indian investors can start investing in Protagenic Therapeutics Inc (PTIX) shares with as little as ₹90.608 or $1 (as of February 13, 2026 at 9:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹906.08 in Protagenic Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on February 13, 2026 at 9:41 pm IST). Based on Protagenic Therapeutics Inc share’s latest price of $0.47 as on February 13, 2026 at 1:59 am IST, you will get 21.2766 shares of Protagenic Therapeutics Inc. Learn more about fractional shares .